Toshiba America Medical Systems announced the Vantage(TM), the company's new 1.5-tesla (1.5T) high-field magnetic resonance imaging (MRI) system, said to be equipped with the world's shortest magnet, has been installed at the first U.S. healthcare facility.
Installed in Radiology, Ltd. at Tucson Imaging Associates in Arizona, U.S., the system also will be displayed for the first time at the Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA).
"The EXCELART Vantage installation at Radiology, Ltd. will be the first of many for Toshiba," said Dane Peshe, director of MRI Business Unit. "Toshiba developed the Vantage to be a patient-friendly MRI system that delivers optimum technical and clinical performance in one package. In addition to the best clinical performance, the MRI system features patient comfort features, such as the ultra-short bore platform to offer greater openness for claustrophobic patients and Toshiba's patented Pianissimo(TM) noise reduction technology, which effectively reduces scan noise by as much as 90 percent."
The system is equipped with a new CPU platform, which is said to offer SuperFASE, a short echo spacing, half-Fourier RF refocused sequence for high-speed 2-D and 3-D T2 weighted imaging -- a technique adapted for imaging vascular structures in the abdomen and chest. With this technique, magnetic resonance angiography (MRA) images of venous and arterial vessels can be simultaneously visualized without the use of contrast agents, according to Toshiba. The EXCELART Vantage also features BasicSoft, an anatomically oriented imaging protocol package. BasicSoft reportedly contains the widest range of standard pulse sequences in the industry, including high-resolution FSE and its single-shot variations of FASE and multi-slab MRA.
The system also is available with optional packages for advanced EPI functional, perfusion, diffusion, peripheral MRA, cardiac imaging, and SuperFASE imaging for higher resolution, high-speed 2-D and 3-D imaging, or non-contrast perfusion and MRA studies.
to Daily News